{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Eye", "query": { "condition": "Eye" }, "page_size": 10 }, "pagination": { "page": 1, "page_size": 10, "total_count": 6027, "total_pages": 603, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Eye&page=2&page_size=10", "previous_page_url": null }, "source": "remote", "last_synced_at": "2026-07-22T18:38:01.369Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT03100942", "title": "Study to Assess Safety and Efficacy of Filgotinib, Lanraplenib and Tirabrutinib in Adults With Active Sjogren's Syndrome", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Sjogren's Syndrome" ], "interventions": [ { "name": "Lanraplenib", "type": "DRUG" }, { "name": "Filgotinib", "type": "DRUG" }, { "name": "Tirabrutinib", "type": "DRUG" }, { "name": "Lanraplenib placebo", "type": "DRUG" }, { "name": "Filgotinib placebo", "type": "DRUG" }, { "name": "Tirabrutinib placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Gilead Sciences", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "18 Years to 75 Years" }, "enrollment_count": 152, "start_date": "2017-05-01", "completion_date": "2019-10-02", "has_results": true, "last_update_posted_date": "2020-10-23", "last_synced_at": "2026-07-22T18:38:01.369Z", "location_count": 34, "location_summary": "Mesa, Arizona • Phoenix, Arizona • Covina, California + 31 more", "locations": [ { "city": "Mesa", "state": "Arizona" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Covina", "state": "California" }, { "city": "Upland", "state": "California" }, { "city": "Denver", "state": "Colorado" } ], "official_url": "https://clinicaltrials.gov/study/NCT03100942" }, { "nct_id": "NCT07380256", "title": "Visual Influences on Vestibular Adaptation", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Vestibular Hypofunction", "Binocular Vision Abnormalities", "Reduced Vision" ], "interventions": [ { "name": "StableEyes: Incremental Vestibulo-Ocular Reflex Adaptation (IVA)", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "Emory University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "60 Years", "sex": "ALL", "summary": "18 Years to 60 Years" }, "enrollment_count": 100, "start_date": "2026-02-04", "completion_date": "2029-12", "has_results": false, "last_update_posted_date": "2026-04-17", "last_synced_at": "2026-07-22T18:38:01.369Z", "location_count": 2, "location_summary": "Atlanta, Georgia", "locations": [ { "city": "Atlanta", "state": "Georgia" }, { "city": "Atlanta", "state": "Georgia" } ], "official_url": "https://clinicaltrials.gov/study/NCT07380256" }, { "nct_id": "NCT01834196", "title": "Swept-Source Optical Coherence Tomography for Noninvasive Retinal Vascular Imaging", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Retinal Vascular Disease" ], "interventions": [ { "name": "Swept-Source Optical Coherence Tomography", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "Duke University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 13, "start_date": "2012-08", "completion_date": "2012-11", "has_results": false, "last_update_posted_date": "2017-03-21", "last_synced_at": "2026-07-22T18:38:01.369Z", "location_count": 1, "location_summary": "Durham, North Carolina", "locations": [ { "city": "Durham", "state": "North Carolina" } ], "official_url": "https://clinicaltrials.gov/study/NCT01834196" }, { "nct_id": "NCT01024322", "title": "Collagen Crosslinking With Ultraviolet-A in Asymmetric Corneas", "overall_status": "TERMINATED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Keratoconus", "Ectasia", "Degeneration" ], "interventions": [ { "name": "Ciprofloxicine or Vigamox or other.", "type": "DRUG" }, { "name": "Nonsteroidal (Acular, Voltaren Xibrom, etc)", "type": "DRUG" }, { "name": "Steroid (FML, Pred Forte, Flarex, etc.)", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Cxlusa", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "8 Years", "maximum_age": null, "sex": "ALL", "summary": "8 Years and older" }, "enrollment_count": 1189, "start_date": "2009-10-01", "completion_date": "2017-02-03", "has_results": false, "last_update_posted_date": "2018-10-11", "last_synced_at": "2026-07-22T18:38:01.369Z", "location_count": 3, "location_summary": "Miami, Florida • Rockville, Maryland • Fairfax, Virginia", "locations": [ { "city": "Miami", "state": "Florida" }, { "city": "Rockville", "state": "Maryland" }, { "city": "Fairfax", "state": "Virginia" } ], "official_url": "https://clinicaltrials.gov/study/NCT01024322" }, { "nct_id": "NCT04940429", "title": "Eye Movement Testing in Patients With Obesity and the Impact of Weight Loss Surgery", "overall_status": "TERMINATED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Bariatric Surgery Candidate", "Obesity, Morbid" ], "interventions": [ { "name": "Neurofit", "type": "DEVICE" }, { "name": "Psychometric hepatic encephalopathy score", "type": "DIAGNOSTIC_TEST" } ], "intervention_types": [ "DEVICE", "DIAGNOSTIC_TEST" ], "sponsor": "Stanford University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 19, "start_date": "2018-11-27", "completion_date": "2021-06-17", "has_results": false, "last_update_posted_date": "2021-06-25", "last_synced_at": "2026-07-22T18:38:01.369Z", "location_count": 1, "location_summary": "Redwood City, California", "locations": [ { "city": "Redwood City", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT04940429" }, { "nct_id": "NCT03937856", "title": "Smartphone Mindfulness Meditation for Patients With Rheumatic Diseases", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Inflammatory Arthritis", "Scleroderma", "Myositis", "Sjogren's Syndrome", "Systemic Lupus Erythematosus", "Vasculitis" ], "interventions": [ { "name": "Calm- Mindfulness Meditation smartphone application", "type": "BEHAVIORAL" } ], "intervention_types": [ "BEHAVIORAL" ], "sponsor": "Johns Hopkins University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 49, "start_date": "2019-05-07", "completion_date": "2021-04-22", "has_results": false, "last_update_posted_date": "2021-04-26", "last_synced_at": "2026-07-22T18:38:01.369Z", "location_count": 1, "location_summary": "Baltimore, Maryland", "locations": [ { "city": "Baltimore", "state": "Maryland" } ], "official_url": "https://clinicaltrials.gov/study/NCT03937856" }, { "nct_id": "NCT00001737", "title": "Cyclosporin Implant to Treat Uveitis", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Eye Disease", "Inflammation", "Uveitis" ], "interventions": [ { "name": "Cyclosporin A Implant", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "National Eye Institute (NEI)", "sponsor_class": "NIH", "healthy_volunteers": false, "eligibility": { "minimum_age": null, "maximum_age": null, "sex": "ALL", "summary": "Not listed" }, "enrollment_count": 10, "start_date": "1998-05", "completion_date": "2004-03", "has_results": false, "last_update_posted_date": "2008-03-04", "last_synced_at": "2026-07-22T18:38:01.369Z", "location_count": 1, "location_summary": "Bethesda, Maryland", "locations": [ { "city": "Bethesda", "state": "Maryland" } ], "official_url": "https://clinicaltrials.gov/study/NCT00001737" }, { "nct_id": "NCT05491746", "title": "Diabetic Retinopathy Tethered Augmented Reality With Eye4 Study", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Diabetic Retinopathy", "Low Vision" ], "interventions": [ { "name": "Eye4", "type": "DEVICE" }, { "name": "Placebo", "type": "OTHER" } ], "intervention_types": [ "DEVICE", "OTHER" ], "sponsor": "Eyedaptic", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 20, "start_date": "2022-07-01", "completion_date": "2022-10-01", "has_results": false, "last_update_posted_date": "2023-02-15", "last_synced_at": "2026-07-22T18:38:01.369Z", "location_count": 1, "location_summary": "Laguna Hills, California", "locations": [ { "city": "Laguna Hills", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT05491746" }, { "nct_id": "NCT00061542", "title": "Safety and Efficacy Study of BETOPTIC S 0.25% and Timolol Gel-forming Solution 0.25% and 0.5% in Pediatric Patients With Glaucoma or Ocular Hypertension", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Glaucoma", "Ocular Hypertension" ], "interventions": [ { "name": "BETOPTIC S (betaxolol HCl)", "type": "DRUG" }, { "name": "Timolol Gel-forming Solution (TGFS)", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Alcon Research", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "1 Week", "maximum_age": "5 Years", "sex": "MALE", "summary": "1 Week to 5 Years · Male only" }, "enrollment_count": 105, "start_date": "2003-01", "completion_date": "2006-11", "has_results": false, "last_update_posted_date": "2016-11-18", "last_synced_at": "2026-07-22T18:38:01.369Z", "location_count": 1, "location_summary": "Fort Worth, Texas", "locations": [ { "city": "Fort Worth", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT00061542" }, { "nct_id": "NCT04792580", "title": "The Effects and Safety of 5% Lifitegrast Ophthalmic Solution in Subjects With Dry Eye Disease in Ocular Graft-versus-Host Disease", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "EARLY_PHASE1" ], "conditions": [ "Graft-versus-host-disease", "Ocular Graft-versus-host Disease" ], "interventions": [ { "name": "Lifitegrast 5% Ophthalmic Solution", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Richard W Yee, MD", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "85 Years", "sex": "ALL", "summary": "18 Years to 85 Years" }, "enrollment_count": 30, "start_date": "2022-10-22", "completion_date": "2024-04-30", "has_results": false, "last_update_posted_date": "2024-07-15", "last_synced_at": "2026-07-22T18:38:01.369Z", "location_count": 1, "location_summary": "Bellaire, Texas", "locations": [ { "city": "Bellaire", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT04792580" } ] }